Annual report pursuant to Section 13 and 15(d)

Consolidating Condensed Financial Information of Guarantor Subsidiaries - Consolidating Condensed Statement of Cash Flows (Detail)

v3.5.0.2
Consolidating Condensed Financial Information of Guarantor Subsidiaries - Consolidating Condensed Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Sep. 24, 2016
Sep. 26, 2015
Sep. 27, 2014
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities $ 151,426 $ 87,449 $ 126,467
Additions to property, plant and equipment (27,622) (22,030) (17,173)
Payments to acquire companies, net of expenses (69,001) (38,384) (20,282)
Proceeds from disposal of land, buildings, etc. 3,911 0 8,737
Change in restricted cash and cash equivalents. 2,247 1,126 (14,283)
Maturities of short term investments 0 9,997 17,820
Investment in short-term investments 0 (17) (10,000)
Other investing activities (730) (546) 0
Intercompany investing activities 0 0 0
Net cash used in investing activities (91,195) (49,854) (35,181)
Repayments on revolving line of credit (419,000) (312,000) (301,000)
Borrowings on revolving line of credit 419,000 312,000 278,000
Repayments of long-term debt (400,307) (50,289) (367)
Issuance of long-term debt 400,000 0 0
Proceeds from issuance of common stock 324 200 1,165
Excess tax benefits from stock-based awards 6,869 2,154 498
Repurchase of common stock (10,873) (18,497) (2,332)
Payments of contingent consideration (2,026) 0 0
Payment of deferred financing costs (7,560) (258) (3,090)
Distribution to parent 0 0 0
Distribution to noncontrolling interest (592) (1,680) (633)
Intercompany financing activities 0 0 0
Net cash used by financing activities (14,165) (68,370) (27,759)
Effect of exchange rates on cash (668) (317) (7)
Net increase (decrease) in cash and cash equivalents 45,398 (31,092) 63,520
Cash and cash equivalents at beginning of year 47,584 78,676 15,156
Cash and cash equivalents at end of year 92,982 47,584 78,676
Eliminations [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities (4,883) (6,719) (2,534)
Additions to property, plant and equipment 0 0 0
Payments to acquire companies, net of expenses 0 0 0
Proceeds from disposal of land, buildings, etc. 0   0
Change in restricted cash and cash equivalents. 0 0 0
Maturities of short term investments 0 0 0
Investment in short-term investments 0 0 0
Other investing activities 0 0  
Intercompany investing activities 130,183 101,752 111,652
Net cash used in investing activities 130,183 101,752 111,652
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt 0 0 0
Issuance of long-term debt    
Proceeds from issuance of common stock 0 0 0
Excess tax benefits from stock-based awards 0 0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration    
Payment of deferred financing costs 0 0 0
Distribution to parent 4,883 6,719 2,534
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities (130,183) (101,752) (111,652)
Net cash used by financing activities (125,300) (95,033) (109,118)
Effect of exchange rates on cash 0 0 0
Net increase (decrease) in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Parent [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 3,514 (16,823) (4,139)
Additions to property, plant and equipment (4,513) (2,721) (6,721)
Payments to acquire companies, net of expenses (69,001) (38,384) 0
Proceeds from disposal of land, buildings, etc. 0   0
Change in restricted cash and cash equivalents. 2,247 1,126 (14,283)
Maturities of short term investments 0 9,997 17,820
Investment in short-term investments 0 (17) (10,000)
Other investing activities (730) (546)  
Intercompany investing activities (83) (15,789) (6,726)
Net cash used in investing activities (72,080) (46,334) (19,910)
Repayments on revolving line of credit (419,000) (312,000) (301,000)
Borrowings on revolving line of credit 419,000 312,000 278,000
Repayments of long-term debt (400,286) (50,262) (243)
Issuance of long-term debt 400,000    
Proceeds from issuance of common stock 324 200 1,165
Excess tax benefits from stock-based awards 6,869 2,154 498
Repurchase of common stock (10,873) (18,497) (2,332)
Payments of contingent consideration    
Payment of deferred financing costs (7,560) (258) (3,090)
Distribution to parent 0 0 0
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities 127,436 103,326 109,057
Net cash used by financing activities 115,910 36,663 82,055
Effect of exchange rates on cash (1,466) (697) 27
Net increase (decrease) in cash and cash equivalents 45,878 (27,191) 58,033
Cash and cash equivalents at beginning of year 36,280 63,471 5,438
Cash and cash equivalents at end of year 82,158 36,280 63,471
Non-Guarantor Subsidiaries [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 2,654 7,372 7,420
Additions to property, plant and equipment (717) (405) (1,027)
Payments to acquire companies, net of expenses 0 0 0
Proceeds from disposal of land, buildings, etc. 0   0
Change in restricted cash and cash equivalents. 0 0 0
Maturities of short term investments 0 0 0
Investment in short-term investments 0 0 0
Other investing activities 0 0  
Intercompany investing activities 0 0 0
Net cash used in investing activities (717) (405) (1,027)
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt 0 0 0
Issuance of long-term debt    
Proceeds from issuance of common stock 0 0 0
Excess tax benefits from stock-based awards 0 0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration    
Payment of deferred financing costs 0 0 0
Distribution to parent (4,883) (6,719) (2,534)
Distribution to noncontrolling interest (592) (1,680) (633)
Intercompany financing activities 2,747 (1,574) 2,595
Net cash used by financing activities (2,728) (9,973) (572)
Effect of exchange rates on cash 464 222 (18)
Net increase (decrease) in cash and cash equivalents (327) (2,784) 5,803
Cash and cash equivalents at beginning of year 10,022 12,806 7,003
Cash and cash equivalents at end of year 9,695 10,022 12,806
Guarantor Subsidiaries [Member]      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 150,141 103,619 125,720
Additions to property, plant and equipment (22,392) (18,904) (9,425)
Payments to acquire companies, net of expenses 0 0 (20,282)
Proceeds from disposal of land, buildings, etc. 3,911   8,737
Change in restricted cash and cash equivalents. 0 0 0
Maturities of short term investments 0 0 0
Investment in short-term investments 0 0 0
Other investing activities 0 0  
Intercompany investing activities (130,100) (85,963) (104,926)
Net cash used in investing activities (148,581) (104,867) (125,896)
Repayments on revolving line of credit 0 0 0
Borrowings on revolving line of credit 0 0 0
Repayments of long-term debt (21) (27) (124)
Issuance of long-term debt    
Proceeds from issuance of common stock 0 0 0
Excess tax benefits from stock-based awards 0 0 0
Repurchase of common stock 0 0 0
Payments of contingent consideration (2,026)    
Payment of deferred financing costs 0 0 0
Distribution to parent 0 0 0
Distribution to noncontrolling interest 0 0 0
Intercompany financing activities 0 0 0
Net cash used by financing activities (2,047) (27) (124)
Effect of exchange rates on cash 334 158 (16)
Net increase (decrease) in cash and cash equivalents (153) (1,117) (316)
Cash and cash equivalents at beginning of year 1,282 2,399 2,715
Cash and cash equivalents at end of year $ 1,129 $ 1,282 $ 2,399